Quality Surgical Solutions Anatomics is a medical technology company that has been manufacturing high-quality medical devices, prosthetics and software solutions since 1995. Based in Melbourne Australia, Anatomics manufactures high quality patient specific implants for global distribution and in-licenses novel technology for Australian and New Zealand distribution. We strive to be recognised as a trusted and innovative provider of quality surgical products. Our mission is to work in partnership with healthcare professionals and medical device companies to provide the highest quality surgical products. We are a company of experienced and dedicated team members who strive for better surgical outcomes by initiating …

72 similar entities Type: SMB Activities: deeptech manufacturing healthtech Technologies: Synthetic Biology

Answers when you need them POCD are changing the way healthcare is delivered by sourcing the finest quality technology and brining it to Australia and New Zealand for all medical professionals to take advantage of. We are passionate about providing specialist services in near‐patient diagnostics and in‐vitro testing - including equipment and products tailored to the requirements of our customers. We have extensive experience in the following forms of equipment and product delivery: * Supply of laboratory consumables * Supporting corporate health programs * Running state‐wide public health initiatives * Implementing national pharmacy health programs The company began operations in …

64 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Starpharma is a global biopharmaceutical company and a world leader in the development of dendrimers. Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for respiratory viruses, DEP® drug delivery and VivaGel®. Medical Devices, Pharmaceuticals, and Dendrimer Drug Delivery

61 similar entities Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology

A leading basic research institute addressing fundamental questions in molecular biology. Part of Vienna BioCenter. The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 40 countries, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, microscopy, immunology and cancer, developmental biology, chromosome biology, and computational biology. Molecular Biology, Disease Mechanisms, Computational biology, Immunology, Cell Biology, Chromosome Biology, Gene Regulation, Developmental Biology, and Microscopy

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech Technologies: Synthetic Biology

Vienna BioCenter is a leading life sciences campus in Europe, and we are hiring! Vienna BioCenter is a leading life sciences location in Europe, offering a unique combination of research, education and companies on a single campus: 2,800 employees, 1,500 students, 145 research groups, and 39 biotech companies. Over the last thirty years, the Vienna BioCenter has developed into one of the leading multi-disciplinary biomedical research centers in Europe and into the premier location for Life Sciences in Austria. Its institutions and companies are among the European leaders in their field and have been able to attract excellent scientists as …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Brain-Computer Interfaces & Neurotechnology g.tec medical engineering was founded in 1999 as a spin-off from the Technical University in Graz, Austria. Christoph Guger and Günter Edlinger developed the first commercial Brain-Computer Interface (BCI) system at this time. As a producer of state-of-the-art invasive and non-invasive BCI systems with sales and research partners worldwide, g.tec is a leader in the fields of BCI, medical devices, neurotechnology, neurorehabilitation and biosignal processing with branches in Schiedlberg and Graz (Austria), Barcelona (Spain), and New York (USA). g.tec’s BCI systems are realized by four major principles: slow waves, steady-state visual evoked potentials (SSVEP), motor imagery …

Type: SMB Activities: healthtech deeptech manufacturing biotech Technologies: Affective Computing Synthetic Biology

#Bedrafter #Drafthealthcare Communication group specialized in Healthcare. 40 years committed to the health of brands and a high knowledge of the environment in all therapeutic areas. We have a multidisciplinary team: doctors, chemicals, pharmacists, publicists, journalists, photographers, economists, graduates in Fine Arts and Audiovisual Communication. More than 20 professionals sharing knowledge and providing global solutions in specialized health and medical devices. The group consists of three divisions that add strength to ensure a global, complete and integral response. Draft Advertising: The Advertising and Communication Agency. Draft G5: Specialized Division in Special Projects. Digital Draft: Consulting and Development of Digital Projects. …

35 similar entities Type: SMB Activities: martech healthtech Technologies: Synthetic Biology

Meet Consumer Demands | Simplify Your Labels | Reformulate & Develop Established in 2000, Ulrick & Short is dedicated to the development and supply of clean label, additive free ingredients to food manufacturers. We offer a comprehensive range of clean label, functional native starches, fat replacers, functional flours, bakery glazes, phosphate replacers and proteins from a range of crops and cereals. These unique specialist ingredients are backed up and supported by our experienced technologists who can work with you in our development kitchens and take solutions into your factory, getting you maximum value from our products, fast tracking your development …

Type: SMB Activities: foodtech Technologies: Synthetic Biology

First-in-class wound dressings with nanotechnology aiming to prevent clinical infection and promote wound closure. Nanordica Medical is an Estonian MedTech company. We are pioneers in advanced antibacterial nanotechnology preventing and curing topical bacterial infections. The company applied for several international patents and develops its first product, an advanced antibacterial wound dressing. A pilot clinical trial in the largest Estonian hospital showed Nanordica's wound dressing cures wounds that can not be cured with other methods and causes fewer adverse effects compared to the current leading antibacterial dressing. Our long-term goal is to be a world-wide renowned global deep tech company developing …

2 similar entities Type: SMB Activities: manufacturing healthtech deeptech nanotech Technologies: Synthetic Biology

Redefining treatment for lung patients 🫁 Gilbert is a spin-off of Delft University of Technology (TU Delft) and a group of companies based at the High Tech Campus in Eindhoven, The Netherlands. It’s our mission to make medical treatment easier and more effective for millions of lung patients to extend and improve lives, while reducing the burden of care on the healthcare systems. We redefine treatment for lung patients. We believe in delivering a social contribution to the well being of people in general and stimulating healthcare improvements in particular, using the ever evolving technological application possibilities created by science. …

8 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

A novel and safe approach for treating cognitive disorders Umecrine Cognition is developing a completely new type of drug for neurological disorders in the brain that can occur as a result of a number of underlying diseases and lead to severely reduced cognition and alertness. The results from an internationally recognized clinical phase 2 study indicate that the company’s most advanced drug candidate, golexanolone, improves brain signaling and cognition and alertness in patients with hepatic encephalopathy. The continued development of golexanolone is initially focused on patient groups whose symptoms have arisen as a result of chronic liver diseases, but the …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Because nobody should choose whether to eat or take care The Banco Farmaceutico Ets Foundation, since 2000, collects and recovers drugs (CA 1.5 million a year - both from over the counter and with a prescription obligation) to be donated to over 1,700 welfare bodies that offer free socio -health assistance to the indigent ones. He does it, mainly, through 3 activities: Drug collection day On the second Saturday of February of each year, Otre 18,000 volunteers in more than 4,500 pharmacies that adhere to the initiative invite customers to donate one or more drugs for local assistance bodies. Company …

Type: SMB Activities: cleantech greentech Technologies: Synthetic Biology

Finding cures for cardiovascular disease through world-class medical research. The Victor Chang Cardiac Research Institute is dedicated to finding cures for cardiovascular disease through world-class medical research. Renowned for the quality of its scientific breakthroughs, the team at the Institute is working urgently to discover better ways of diagnosing, treating and preventing the onset of heart disease. With over 200 scientists and doctors working together across 23 laboratories in NSW and WA, the Victor Chang Cardiac Research Institute has earned its place on the global stage as one of the most respected medical research facilities in the world. The Institute …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Innovative Oncology Headquartered in Madrid, PharmaMar is a biopharmaceutical company, focused on oncology and committed to research and development which takes its inspiration from the sea to discover molecules with antitumor activity. It is a company that seeks innovative products to provide healthcare professionals with new tools to treat cancer. Its commitment to patients and to research has made it one of the world leaders in the discovery of antitumor drugs of marine origin. PharmaMar has a pipeline of drug candidates and a robust R&D oncology program. It develops and commercializes Yondelis® in Europe and has other clinical-stage programs under …

90 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Controlling Inflammation - developing drugs to treat life threatening and chronic inflammatory diseases InflaRx (Nasdaq: IFRX) is a biopharmaceutical company pioneering anti-inflammatory therapeutics by applying its proprietary anti-C5a and anti-C5aR technologies to discover, develop and commercialize highly potent and specific inhibitors of the complement activation factor C5a and its receptor C5aR. C5a is a powerful inflammatory mediator involved in the progression of a wide variety of inflammatory diseases. InflaRx’s lead product candidate, vilobelimab, is a novel, intravenously delivered, first-in-class, anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical studies …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Development of highly differentiated first-in-class antibody-drug conjugates (ADCs) for treatment of solid tumors. Adcendo is a Danish clinical-stage biotech company headquartered in Copenhagen, dedicated to the development of highly differentiated First-In-Class Antibody-drug conjugates (ADCs) for treatment of solid tumors. In November of 2024, the company announced the closing of a USD 135m series B financing round. With a total sum of USD 240m raised since 2021 and under the leadership of a highly experienced management team, Adcendo is moving forward a growing and highly differentiated pipeline of drug candidates into the clinic. Read more at www.adcendo.com

3 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Reveal cell function with single-cell resolution. Samplix offers a cutting-edge droplet-based instrument for single-cell analysis in immunotherapy research. Our double emulsion technology enables seamless analysis and sorting on flow cytometers. Empower your research today! Xdrop encapsulates living cells and reactive molecules in highly stable double-emulsion droplets that act as microenvironments for rapid cell–cell and cell–molecule interactions during incubation. The droplets are suitable for flow cytometry and sorting. Xdrop Sort can both generate and sort double-emulsion droplets in a user-friendly workflow that does not require any experience with fluorescence-based cell sorters. The limited volume forces fast interactions and causes secreted substances …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Experts in Publishing, Medical Communications, Medical Education and Medical Writing Springer Healthcare Italia is a leading company in scientific and biomedical communication, known through different brands. All over the world, thousands of doctors, pharmacists, nurses and numerous other health professionals use books, magazines, databases and other products and services offered by our group as indispensable tools for study and work. Quality, accuracy, scientific rigor and constant updating of content characterize our editorial products. We publish magazines and books in Italian and English, we develop innovative communication projects for pharmaceutical companies, we offer medical writing services. As provider, Springer Healthcare Italia …

37 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Naturally Innovative CIDP, Naturally Innovative Established in 2004, CIDP is a private and independent Contract Research Organisation (CRO) that carries out high-performance R&D activities. With over 17 years of experience in the clinical research, CIDP has a strong foothold on each continent with centres located in Brazil, India, Mauritius, and Romania offering an ideal platform for all your research projects worldwide. The services provided by CIDP are segmented into five main areas of expertise: Research & Development activities, Preclinical in vitro testing, Clinical research, Biostatistics and Data Management and Regulatory Affairs. CIDP comprises a team of 130 staff members: doctors, …

Type: SMB Activities: deeptech Technologies: Data Analytics Synthetic Biology

Over 22 years of providing contract & permanent staffing solutions to Bostons Biotech and Pharmaceutical Industries. Stratacuity provides contract and permanent placement, managed services and payroll to top Pharmaceutical and Biopharmaceutical companies. We do it with specific expertise from Discovery to Manufacturing, handling a wide range of scientific skill sets to find your needle-in-the-haystack talent. Stratacuity understands that when companies hire better people the chances of new life-saving therapeutics being discovered and approved increase exponentially. Today, there are many firms handling biotech and pharmaceutical recruiting, but do they embrace the importance of the science their client is developing and how …

Type: SMB Activities: biotech deeptech healthtech hrtech Technologies: Synthetic Biology

We Embrace the Challenge in Science Dompé farmaceutici is an international biopharmaceutical company involved in all activities of the pharmaceutical value chain, from research to development, production and marketing. As a long-established family company, we blend the stability that comes from our 130-year heritage with the agility and dynamism of a start-up. We can turn transformative breakthroughs into treatments because we have the right qualities and capabilities to deliver new drugs. Our 160,000 square meter R&D and production site in L’Aquila, Italy, is the heart of Dompé. Here, we conduct vital research, and produce and distribute our primary care and …

84 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Sterling Pharma Solutions is a leading provider of API services to the pharmaceutical industry. Sterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO) with 50+ years’ experience in providing small molecule API development and manufacturing services to the pharmaceutical industry, specialising in handling challenging chemistries. Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) development and manufacturing services. Sterling believes that while science can be complex, partnerships should be simple. That’s why they have redefined the CDMO experience, marked by transparency, collaboration and trust; …

Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology SaaS

Advancing Cancer Treatment Breakthroughs Carcinotech provides comprehensive solid tumor research services to advance drug development and enhance personalized therapy decisions. At the heart of its offerings is the proprietary Carcino3DTM bioprinting technology, which creates assay-ready, 3D tumors derived from patient biopsies. This innovative, translational approach delivers a predictive in vitro model, generating critical insights into therapeutic efficacy, and treatment optimization. Cancer research, 3D bioprinting , Cancer microenvironment, drug testing, oncology, assay services, oncology pre-clinical services, solid tumours, solid tumors, tumour microenvironment, tumor microenvironment, early phase drug development, and early drug discovery

170 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology

Dedicated to transforming the lives of patients with severe and other genetic diseases through innovative gene therapy. Orchard Therapeutics, a Kyowa Kirin company, is a global gene therapy leader focused on ending the devastation caused by genetic and other severe diseases by discovering, developing, and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy. In this approach, a patient’s own blood stem cells are genetically modified outside of the body and then reinserted, with the goal of correcting the underlying cause of disease with a single treatment. Founded in 2015, Orchard’s roots go …

17 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

World leader in cellular stimulation technologies for Health, Beauty & Wellness. LPG® UK is the UK subsidiary of LPG® Group, the world leader in cellular stimulation. Founded in 1986, LPG® Group is a French company that designs and commercialises non-aggressive and non-invasive treatment solutions for the body and face in over 100 countries. These solutions are aimed at healthcare and beauty professionals, as well as the general public. At the heart of LPG® Group’s flagship products are endermologie® treatments, particularly the CELLU M6 Alliance®, which reactivates cells through mechanical massage. These treatments have both medical applications (such as scars, lymphatic …

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Engineering Stroke Solutions ENGINEERING Stroke Solutions Acandis, founded in 2006, is a privately held German medical device company focused on the prevention and treatment of stroke. We have a passion for technology and our engineers are enthusiastic about creating solutions for unmet clinical needs to improve patient’s lives. We strive towards a comprehensive device portfolio and continuous development of products and services to improve stroke care for neurointerventionalists around the globe. The safety of our products has been demonstrated on the bench top and now the efficacy of those products is being proven in clinical trials. As a company we …

24 similar entities Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology

Medical Devices & Digital Health Consultant | Strategy, Commercialization, & Leadership | Serving Startups & Investors Medical Devices and Digital Health Consultant | Strategy, Commercialization, and Leadership Expert | Serving Startups, Investors, and Entrepreneurial Support Organizations If you have a medical technology invention or idea and need to know where to start, have launched into the marketplace and aren’t hitting your targets, or are most anywhere in between, you’ve come to the right place for expert medical device and digital health help. Whether it’s strategic direction, commercialization, fractional leadership or independent board representation, Medical Device Guru, LLC can help you …

66 similar entities Type: SMB Activities: deeptech constructiontech healthtech Technologies: Synthetic Biology

Your full-service medical device contract manufacturer Valtronic is a full-service electronics contract development and manufacturing services provider. Companies worldwide rely on our more than 40 years of experience to develop, industrialize, and manufacture innovative medical and diagnostics devices, including active implants. Our expertise includes microelectronic assemblies, complex flex/rigid PCBA assemblies as well as full device builds. Headquartered in Switzerland, our company operates across three continents with manufacturing sites in Switzerland, the United States and Morocco, and employs more than 350 employees worldwide. Headquartered in Switzerland, our company spreads over three continents with design, development, industrialization and manufacturing sites in Switzerland, …

9 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

ROTOP Pharmaka is a leading German pharmaceutical company that produces cGMP compliant radiopharmaceuticals for diagnostics and therapy in Nuclear Medicine and Molecular Imaging and distributes them in more than 30 countries worldwide. With almost 20 years of experience in the development, production, authorization and distribution of sterile kits for radiolabeled pharmaceuticals ROTOP continuously expands its product portfolio by developing new products and entering new strategic partnerships. Nuclear Medicine, Molecular Imaging, SPECT, CDMO services, Ga68, PET, radiopharmaceutcials, Tc99m, cold kits, GMP manufacturing, Regulatory Affairs, Medical Affairs, Distribution, Q-Unit, Pharmaceutical Development, Ready-to-use-radiopharmaceutcials, Supply, Packaging & Labelling, Logistics, Quality Assurance, Quality Control, Qualified …

43 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

We provide new technological solutions for the medicine of the future. We provide new technological solutions for the medicine of the future. We merge engineering, medicine and design to create medical devices that solve real needs.

118 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Enabling HTS SUPREMAcy Suprema has been founded in 2024 to manufacture the best-in-class High Temperature Superconducting tapes to enable major breakthroughs in multiple applications such as: Magnetic Fusion Reactors (where Superconductors play the role of enabling technology), Electric Grid (transmission, distribution and conversion of electricity), Next Generation Physics Experiments (as future colliders or high field magnets), Bio-Medical devices (as NMR and MRI), Electrical aircrafts and ships and more... Working to enable the HTS SUPREMAcy

Type: SMB Activities: greentech Technologies: Synthetic Biology

Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that elevate patient and physician experiences. Botulinum Toxin, biotechnology, biotech, healthcare, pharmaceuticals, science, research, financial services, and fintech

354 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Precision Radiotherapy From Within BetaGlue Therapeutics is a clinical stage oncology company that has developed an advanced radiotherapy platform enabling localised targeted treatment of both unresectable solid tumours and also treatment of surgical resection margins called YntraDose. radiotherapy, nuclear medicine, oncology, and medical devices

82 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

For some patients we are essential Essential Pharma is an international specialty pharmaceutical company dedicated to maintaining access to clinically differentiated, niche medicines in small patient populations. Our high-impact portfolio has a focus on the central nervous system (CNS), gastroenterology, ophthalmology, and rare disease, and our products treat patients in more than 70 countries. We are proactive in identifying low volume, difficult-to-manufacture therapeutic products, and late-stage clinical development assets that target rare diseases. We specialise in the acquisition of mature, established, branded medicines that are at risk of shortages or discontinuation, working with partners across the globe to ensure their …

12 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

NewAmsterdam Pharma Corporation is a clinical-stage biopharma company creating therapies for cardiometabolic diseases. This page is intended for US audiences. Founded in 2019, NewAmsterdam Pharma Corporation is a late-stage clinical biopharmaceutical company focused on the research and development of transformative therapies for cardiometabolic diseases. Its mission is to improve patient care in populations where traditional therapies have been unsuccessful or are not tolerated. The Company is investigating a selective cholesteryl ester transfer protein (CETP) inhibitor as an LDL-C lowering therapy for patients who cannot be treated optimally with currently available lipid-lowering therapy or for patients with Atherosclerotic Cardiovascular Disease/Familial Hypercholesterolemia …

7 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We aim to protect and heal your skin with our innovative photodynamic therapy medication. Biofrontera AG is a biopharmaceutical company specializing in the development and sale of dermatological drugs and medical cosmetics. The Germany-based company develops and markets innovative products for the care, protection and treatment of the skin. The company’s lead product is the combination of Ameluz®, a topical prescription drug, and medical device BF-RhodoLED® for the photodynamic therapy of certain superficial skin cancers and their precursors. Ameluz® has been marketed in the EU since 2012 and in the United States since May 2016. In the EU, the company …

Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Partner of choice in specialty, hospital, and rare disease medicines Partner of choice in specialty, hospital, and rare disease medicines ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the specialty, hospital, and rare disease medicines they depend on. Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are partnering with innovative biopharma and pharmaceutical development companies to bring medicines to patients. Headquartered in London, UK, we have commercial sales in more …

62 similar entities Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology

First and Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain Mainstay Medical, led by a team of dedicated scientists, executives, engineers, and clinical experts, brings to you ReActiv8®, the first and only FDA-approved restorative treatment for mechanical chronic low back pain. RESTORE Control RESTORE Function RESTORE Stability ReActiv8 LIFE The Company was incorporated in Dublin, Ireland and headquartered in San Diego, CA. It has subsidiaries operating in Ireland, the United States, Australia, Germany and the Netherlands.

8 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Therapeutic Peptides, Inc. is a research company based out of 11725Sun Belt Ct, Baton Rouge, Louisiana, United States.

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Leader in Micro Manufacturing Technologies. We enable our customers to develop products from prototyping to production Potomac Photonics, a leader microfabrication, has an extensive history of helping its clients develop miniature products and bring them to market. Utilizing cutting-edge manufacturing technology, Potomac has been recognized by both commercial and government agencies for innovative contributions to areas such as medical device manufacturing and electronics fabrication. Potomac’s high-tech facility, located in Lanham, MD, is ISO 9001:2008 and ISO 13485:2003 certified. manufacturing, micro manufacturing, and microfabrication

Type: SMB Activities: deeptech manufacturing nanotech Technologies: Synthetic Biology

The Bumble Bee Seafood Company is on a mission to create a new generation of seafood lovers. The Bumble Bee Seafood Company is passionately pursuing its purpose of feeding people’s lives through the power of the ocean. The iconic 120-year-old fishing company consistently aims to deliver delicious, healthy and affordable food to consumers while working hard to find new ways to protect the ocean and those that rely on it. Bumble Bee is firmly anchored in a commitment to connect the world to the ocean by re-defining sourcing, producing and enjoying products from and inspired by the ocean. Bumble Bee’s …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

THINK. MAKE. PROTECT. Founded by healthcare industry professionals with decades of global surgical product experience, Invenio provides a full range of services and solutions for assisting in infection prevention and control. Our vast portfolio of products and capabilities allows us to work with our clientele to tailor products and programs that meet their exacting requirements. Whether the needs are for procedure packs and components, minor kits, or packaging services, our vertically integrated manufacturing provides options for on-shore, near-shore, and far shore to support supply chain resiliency and compliance requirements. Our years of clinical expertise will assist us with selecting the …

53 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Our mission: patient: help inside. We use biotechnology to treat serious illnesses. Amgen was founded in 1980 and is now a globally leading independent biotechnology company, which is represented in almost 100 countries with around 27,000 employees. As a pioneer of biotechnology, we have four decades of experience in research, development and production of innovative human therapy. We focus on illnesses for which there are only a few or no therapy options. Every year, millions of patients with serious illnesses benefit from our therapies worldwide. Our medicines are used in nephrology, cardiology, hematology, oncology, bone health and in chronic inflammatory …

12 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

An industry trade organization for manufacturers of active pharmaceutical ingredients, intermediates and excipients. The Bulk Pharmaceuticals Task Force (BPTF) is an industry trade organization representing manufacturers of active pharmaceutical ingredients, intermediates and excipients. BPTF addresses regulatory and plant operations issues related to current Good Manufacturing Practices compliance. BPTF establishes sound working relationships with regulators, allied industries and the public and serves as a reliable source for the development and implementation of balanced regulations and industry guidance resources. BPTF undertakes this advocacy on behalf of its member companies to achieve drug product and drug substance supply chain safety for consumers.

Type: SMB Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

Avadel (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. We are disrupting paradigms where it’s needed most – starting with narcolepsy. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. At Avadel, our core values foster an atmosphere of transformation and collaboration. In everything we do, we consider the patient experience, listening to their needs as we pursue the development and delivery of medicines that will transform the treatment landscape and have the greatest impact on people living with sleep disorders. Learn more …

4 similar entities Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology

The leading international supplier to the microbiology and tissue culture industries Don Whitley Scientific is a leading international supplier of innovative equipment and services to the microbiology and tissue culture industries. We develop, manufacture, market and service instrumentation and associated products for the public and private sector - primarily for use in hospitals, public health laboratories, food testing organisations and research institutions. We now have the largest, most comprehensive range of workstations specifically designed for the study of anaerobes and microaerophiles. Automated microbiology and cell culture equipment, Contract microbiology laboratory, and Service and maintenance contracts

116 similar entities Type: SMB Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

İSPAK Flexible Packaging Industry Inc. Since 1974, İSPAK has been operating in the flexible packaging sector and has been serving many leading companies of our country and the world with its products. Producing packaging solutions and products for all kinds of processed food, confectionery, chocolate, milk and dairy products, drugs, cosmetics, cigarettes, drinks, white goods, isolation products and products, is rapidly growing and growing in a rapid manner and many "first" in the sector continues to sign. Dear knowledge is one of the leading principles of İSPAK to develop solutions to the different and new needs of its customers with …

Type: SMB Activities: foodtech Technologies: Synthetic Biology

We deliver exquisite enzymes for the betterment of human health. Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic …

12 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Sareum Holdings (AIM:SAR) is a clinical-stage biotechnology company developing next generation kinase inhibitors for autoimmune disease and cancer. The Company is focused on developing next generation small molecules which modify the activity of the JAK kinase family and have best-in-class potential. Its lead candidate, SDC-1801, simultaneously inhibits TYK2 and JAK1. SDC-1801 is a potential treatment for a range of autoimmune diseases and has entered Phase 1a/b clinical development with an initial focus on psoriasis. Sareum has an economic interest in SRA737, a clinical-stage Chk1 inhibitor which it originally developed in collaboration with several Cancer Research UK-related organisations. SRA737 has shown …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

The natural solution for drug delivery DelSiTech is a drug delivery and drug development company based in Turku, Finland. DelSiTech has developed a unique proprietary technology making it a world leader in advanced biodegradable silica-based drug delivery. The technology has successfully been applied to the controlled release of small molecules, biopharmaceuticals and viral vectors with a focus on parenteral and local administration. We can work with you from early feasibility testing to clinical proof of concept; the technology can also be licensed to industry partners. With the DelSiTechTMSilica Matrix, we can create novel products, provide alternative administration opportunities, and extend …

21 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

"Creating the future of mobility to realise dreams" #MobilityMadePossible We are a multi-award winning manufacturer of some of the world's most advanced prosthetic technology, bespoke seating solutions and orthotic devices. We combine clinical expertise and pioneering innovation to redefine mobility. Our evidence-based approach and commitment to continuously challenging possibilities ensures our mobility solutions prioritise the health and long-term health of our users. Through science, technology, and a clear focus on people, we make mobility possible. Lower limb prosthetic products, Prosthetic Service, Orthotic Service, Special Seating, Private Clinic, Clinical Studies, Carbon Fibre Technology, Microprocessor Technology, Medical Devices, Medical Technology, Specialist Rehabilitation, …

Type: SMB Activities: manufacturing healthtech deeptech transporttech Technologies: Synthetic Biology

ARC Medical // ARC Rail Training // ARC Plant and Civils Training Experienced, established, trusted and proven... We are specialists in Rail Training, Plant & Civils Training, Health Safety Training and also Medicals and Drug & Alcohol Screenings. ARC has grown into a group of four companies, recognised largely as a leading Training Provider with training centres in South Wales and London. From our early beginnings as a dedicated Rail Training provider, we have evolved into a multi-faceted, national provider of: - Rail Training - Rail Apprentices - Medicals and Drug & Alcohol Screening - Occupational Health & Safety Training …

Type: SMB Activities: edtech Technologies: Synthetic Biology

Delivering state-of-the-art central lab services across the globe ACM Global Laboratories, an affiliate of Rochester Regional Health in Rochester, New York, is a recognized leader global clinical trial testing services. ACM Global Laboratories operates in more than 65 countries around the globe, with wholly owned facilities in the U.S.A., England, India, and Singapore. Our full-time staff of laboratory experts performs more than 20 million tests annually, spanning all medical disciplines including pathology, microbiology, molecular diagnostics, toxicology and more. For more information, visit www.ACMGlobalLab.com or call 1-866-405 0400 Central Laboratory Testing for Global Clinical Trials, Central Laboratory Services, Clinical Trials Testing, …

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Discover a unique cGMP, in a unique setting, in a unique country. Welcome to FinVector, Kuopio, Finland. Welcome to FinVector, a leading cGMP manufacturer of viral-based products with a strong commitment to restoring hope, purpose and a true sense of belonging for those living with chronic health conditions. FinVector is owned by Ferring Ventures S/A. Learn more: www.finvector.com Instagram: @finvectorians - https://www.instagram.com/finvectorians/ LinkedIn: FinVector Oy - https://www.linkedin.com/company/finvector/ GMP, Manufacturing, Biopharmaceuticals, Gene therapy, and Virus production

Type: SMB Activities: manufacturing deeptech Technologies: Synthetic Biology

Global Leaders in Mammalian Cell Line Development KBI Biopharma and Selexis SA are consolidating operations as one organization under the KBI Biopharma name. This streamlined approach supports customers in accelerating drug development and manufacturing, creating greater flexibility, efficiencies, and a simplified partner experience. You can follow us on the KBI Biopharma page to stay up-to-date on the latest news, events, and happenings. Cell Line Development, HTS, Cell Line Engineering, Contract Biological Services, Stable Cell Line Development, Cell Engineering, Variant Screening, Research Cell Banks, Monoclonal Antibodies, Whole Genome Sequencing, Bispecific Antibodies, CDMO, Monoclonality Assessment, Biotechnology, Biosimilars, Cell line engineering, Genetic engineering, …

142 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Plexus Ventures is a prominent healthcare advisory boutique. Our team of professionals are located in markets all over the world – the United States, Europe, and the Asia-Pacific market, including China and Japan – enabling us to combine local knowledge with global reach. pharmaceutical, drug delivery, biotechnology, consumer & OTC, business development & consulting, out-licensing, in-licensing, divestments, acquisitions, global pharmaceutical market experts, marketing & sales, project management, biosimilars, medical device, and consultants

151 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Lockwood collaborates with clients in the pharmaceutical, biotech, and medical device industries to identify effective, holistic, science-based strategies to address their objectives through medical and market access communications. Our clients count on us to challenge their assumptions, and help them creatively navigate around obstacles. From strategy through execution, we focus on accuracy, transparency, and scientific value to create programs that are evidence-based, clinically relevant, and contribute to the development of our clients’ brands. Over a third of our staff hold advanced scientific or medical degrees, and most work from where they live. Because our flexible structure provides better work-life balance, …

24 similar entities Type: SMB Activities: biotech healthtech Technologies: Synthetic Biology

Developing transformative solutions for patients with infectious diseases and other difficult to treat conditions Positive outcomes. Positive patient stories. These are our priorities at Paratek Pharmaceuticals. As a commercial-stage biopharmaceutical company, we develop transformative solutions for patients with infectious diseases and other difficult to treat conditions, and we believe that we have the right people, the right knowledge and the right drug to make a difference in patients’ lives. Our Mission To create positive stories for patients, physicians and caregivers based on trust and integrity. To accomplish this, our employees work hard to turn everyday decisions into everyday triumphs that …

39 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

From lab to life mAbxience is a Spanish-based company specializing in the development, production, and commercialization of biopharmaceuticals. With over a decade of expertise, our mission is clear: to provide accessible, affordable medicines across the globe, aiming to enhance the quality of life by ensuring universal access to high-caliber medicines. With two market-approved products and a robust pipeline in development, we have established a B2B presence in over 100 markets. Alongside this, we have formed a network with more than 30 partners and built a dedicated team of over 1,000 professionals. Our three multi-product facilities, located in Europe and South …

87 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options. Our vision is grounded in our RTGel® drug delivery technology, our promising pipeline, and a collaborative drive for bold results. Our existing technology: the RTGel drug delivery technology has the potential to be applied to a variety of unmet medical needs. RTGel reverse-thermal hydrogel is liquid at lower temperatures and converts to gel form at body temperature, offering the opportunity to make local therapy a more effective treatment. Our promising pipeline: Ranging from …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We help Scientist build knowledge about their Biopharmaceuticals with our SmartEnzymesTM! Genovis offers a unique range of rapid and easy to use enzymatic tools primarily for the biopharmaceutical industry. Available worldwide, these SmartEnzymesTM are supplied in innovative formats for the development, production and quality control of biological drugs such as monoclonal antibodies, ADCs, biosimilars and bispecifics. The Genovis SmartEnzymes are widely used for the digestion, de-glycosylation and conjugation of the target molecule and are an ideal companion to popular analytical techniques like LC-MS. Within the portfolio there are enzymes specific for: IgG digestion - FabRICATORTM, FabALACTICATM, GingisKHANTM, FabULOUSTM & FabRICATOR …

2 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Improves lives for patients suffering from mental illness and substance use disorder 💚 Orexo is a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs. On the US market, Orexo provides innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with leading partners. Total net sales in 2022 amounted to SEK 624 million, and the number of employees to 126. Orexo is listed on Nasdaq Stockholm's main list and is available as an …

Type: SMB Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology

Ending malaria, rewriting the future MMV is a leading product development partnership (PDP) in the field of antimalarial drug research and development. Our vision is a world in which innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and ultimately help to eradicate this terrible disease. Our success in research and access & product management comes from our extensive partnership network of over 375 pharmaceutical, academic and endemic-country partners in 50 countries. www.mmv.org www.facebook.com/medicinesformalaria www.twitter.com/medsformalaria www.youtube.com/user/MMVmeds4malaria http://plus.google.com/+mmvorgmedsformalaria Research and Development, Product Development Partnership (PDP), Medicines, and Malaria

50 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Symphogen A/S, a Servier company and the Centre of Excellence for Antibodies, operates within in research, early clinical stages and CMC biologics development from research to market. Supporting Servier’s commitment to improve patients health and the R&D strategy within oncology and immune-oncology - Symphogen’s strategic focus is to apply our streamlined and effective antibody platform and capabilities in the discovery and early development of highly differentiated antibodies. The aim is to develop novel compounds either as combination or as stand-alone therapies for difficult to treat cancers. oncology, immune-evasive, and AXL

155 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

STERIS offers customized solutions for a variety of environments, including the SPD, OR, GI/Endoscopy Suite, and ASC. STERIS Healthcare partners with Customers in the perioperative environment to help elevate patient care in Operating Rooms, GI / Endoscopy Suites, and Sterile Processing Departments across the globe. Our team of advisors puts Customers and their patients first. Through comprehensive solutions in equipment, consumables, devices, and services, we help Customers solve their biggest challenges, leverage opportunities for future growth, and advance the care of patients every day.

60 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Canada’s Drug and Health Technology Agency. As of May 1, 2024, CADTH is now Canada's Drug Agency. Please follow our new LinkedIn page at linkedin.com/company/cda-amc, as this page will no longer be updated or monitored. Health research, Health technology assessment, Economic evaluation of health technologies, Knowledge mobilization, Cost-effectiveness analysis, Critical appraisal, Network meta-analysis, Systematic reviews, and Patient engagement

15 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

We are a biopharmaceutical company dedicated?to transforming the future for underserved, global patient populations in bone health and related areas. We consistently embrace opportunities to improve the lives of our patients, their caregivers, our communities, our partners, and each other.

323 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Discover Your Next Breakthrough PsychoGenics is a preclinical CRO with expertise in CNS and orphan disorders. Our mission is to provide the best validated disease models and comprehensive preclinical capabilities to help companies discover the next generation of treatments for severely disabling CNS and orphan disorders, and reduce the attrition rate in clinical development. We are known for our cutting-edge translational approach to research, our customized solutions, the breadth and quality of our work, as well as for our ability to identify statistically relevant phenotypic changes that help our clients quantify the efficacy of their treatments before they move into …

40 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Transforming Research, Advancing Health Together At Cerba Research we provide world-class clinical research to help life science companies successfully develop the predictive and precision medicines of the future and help people live healthier lives. We are committed to delivering the next generation of healthcare by transforming research and advancing health together. We support you with industry-leading excellence in oncology, virology, vaccine development, immunology, and cell and gene therapy, together with world-class deep specialty testing, from next generation sequencing to flow cytometry, molecular diagnostics, IHC & and spatial Omics, and bioinformatics. We are committed to helping you deliver the next generation …

76 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Data Analytics Synthetic Biology

We develop oral small-molecule and protein therapeutics to treat hereditary angioedema (HAE) and other rare diseases. BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema (HAE) and other rare diseases. We leverage our expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. We are a commercial-stage biotech company with US headquarters in Durham, North Carolina. Our European headquarters is in Dublin, Ireland, and our Discovery Center of Excellence is rooted in Birmingham, Alabama, with many other regional offices …

151 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

More than 80% of new drug development in Japan is supported by CMIC'S efforts. 実は、日本の新薬誕生の約8割に、私たちシミックの力が活かされています。 Voted Best Contract Research Organization (CRO) 2024 by Citeline CMIC Group was the first company to provide CRO (contract research organization) services in Japan. Relevant laws and rules had not been established when the group was first established. The CRO Study Group (which later became the Japan CRO Association) was formed by Mr. Kazuo Nakamura, the current CEO of CMIC Group, and others to conduct promotion and public relations activities and to negotiate with the authorities for the establishment of CROs in Japan. CMIC Group …

Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Your health begins in your skin IMR was founded in 2003 by Dr. Jose María Ricart, and is currently the largest Spanish clinic in full in dermatology and dermo-aesthetic. IMR is a dynamic company for the provision of medical services based in Valencia, with clinics in Valencia, Madrid and Torrent, providing their medical services to the most prestigious private medical centers nationwide such as Quironsalud in Valencia and International Ruber in Madrid. In IMR, more than 100 highly specialized professionals who attend an average of 8,000 patients per month work. Currently, IMR is a national leader in Dermatology, Dermo-East and …

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Health is wealth SVAS Biosana S.p.A. is an Italian Hospital and Health Care company. SVAS Biosana was founded in 1972 and specializes in the distribution of medical appliances. Thanks to the commitment of its Management, this company has been progressively growing and in a few years it has become an important reference point, in Italy and abroad, for the sanitary field. Over time, our society developed an “industrial” project by obtaining the technical skills required to manufacture products under its own brand. The project is achieved through the gradual foundation of different production lines intended to specific articles: Farmex "Incontinence …

21 similar entities Type: SMB Activities: manufacturing healthtech deeptech Technologies: Synthetic Biology

Committed to the patient's health and wellbeing since 1919 LETI Pharma, the Experimental Laboratory for Immunogenic Therapeutics, is an independent, family-owned, biopharmaceutical company. Since its creation, in 1919, LETI Pharma has been working in immunotherapy based on the use of allergens, applying principals of personalized medicine, and a patient approach keeping with the “One Health” philosophy. LETIPharma integrates two lines of business, and several areas of work: HUMAN HEALTH - Immunology and Allergy, centered on the production of allergen extracts for allergy diagnosis and treatment. - Dermatology and skin care, which centers its activity on the development of dermo-pharmaceutical products …

Type: SMB Activities: pettech biotech deeptech healthtech Technologies: Synthetic Biology

More than 55 years working to ensure people have access to their medications, regardless of prevalence. For over 50 years, we have worked to ensure that everyone has access to our medications, regardless of their prevalence, thus improving their quality of life. #WeAreRubió Laboratorios Rubió was founded in 1968 with the goal of marketing medications that, at the time, were not available in our country because they were treatments for low-prevalence diseases. As pioneers in the first drug in Spain for the treatment of ADHD, today we have more than a dozen medications on the market, many of which are …

8 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Helping people heal with 3D printed medical devices made from 4Degra®. Regenerative, resorbable and customisable. Parent company of the 4D Group, 4D Medicine Ltd is dedicated to shaping the future of implantable medical devices made from proprietary resorbable biomaterials. The 4D Group’s technology platform is centred around 4Degra®, a patent protected resorbable photocurable resin based on unique polycarbonate urethane chemistry. A result of 15 years rigorous academic research in leading U.K. universities, 4Degra® promises to free resorbable medical device design from historic constraints and overcome the clinical performance issues of current material options. The first medical devices to be made …

Type: Startup Activities: deeptech biotech healthtech Technologies: 3D Printing Synthetic Biology

Toward the next generation of gene therapy. Spur Therapeutics (formerly Freeline Therapeutics) is a clinical-stage biotechnology company focused on developing life-changing therapies for debilitating chronic conditions. By optimizing every component of our product candidates, we are improving genetic expression and targeted delivery to realize outsized clinical results. Building on the successes of our two potential first-in-class therapies for Gaucher disease and adrenomyeloneuropathy (AMN), we’re moving from rare diseases toward more widespread conditions, including forms of Parkinson’s and dementia, and even certain cardiovascular diseases. Expanding our impact, and pushing forward to new frontiers of genetic medicine. Toward life-changing therapies, and brighter …

88 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

To disrupt the endodontic device and consumable market by setting a new standard of care. Odne AG (formerly Lumendo AG), has its roots in a groundbreaking collaboration between two renowned Swiss institutions: the Swiss Federal Institutes of Technology in Lausanne and Zürich (EPFL & ETH Zürich). Founded in 2018, Odne’s journey began by licensing cutting-edge technology assets from these esteemed institutes. Odne is committed to pioneering the future of endodontics through advanced technology and innovative solutions. Endodontics, the field of dental medicine that deals with root canal treatments, has been marred by complexity and unpredictability. Odne is on a mission …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Rewriting the rules of antiviral drug discovery using the power of HI+AI. Thousands of viruses have the potential to infect humans, but the number of available antiviral drugs can be counted in the tens. The vast diversity of viruses, combined with their rapid mutation rate—as starkly evidenced by the recent Covid-19 pandemic—makes antiviral drug discovery exceptionally challenging. At Elnora AI, we stand at the crossroads of artificial intelligence and drug discovery. Our mission is to chart a new course for antiviral drugs by focusing on host cells rather than directly targeting viruses. This innovative approach provides potential resistance to viral …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology A.I.

nanoMIPs - synthetic antibodies with robust characteristics and secure supply Our proprietary technology includes a novel method to make nanoMIPs which circumvents the drawbacks of traditional MIP manufacturing methods. NanoMIPS are, as the name suggests, nanostructured polymer particles typically containing a single binding site for their target. They can also be fused to solid substrates, such as sensor surfaces, if required. The robust nature of MIPs and nanoMIPs make them ideal reagents for a wide range of applications including point-of-care diagnostics and in field based testing. As they are synthetic polymers, MIPs can withstand harsh chemical environments such as extremes …

Type: Startup Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

Look closer. See further. Haag-Streit UK, headquartered in Harlow, Essex, is a leading UK provider of diagnostic and surgical equipment for ophthalmologists, optometrists, and orthoptists. It designs, manufactures, and distributes a complete portfolio of medical devices, including; slit lamps, biometers, perimeters, OCT devices, lasers, medical simulators, and microscopes. It also provides a comprehensive range of gold-standard micro-surgical instruments and procedures & implants. HS-UK is the Sole UK Distributor for a number of leading brands, such as; Haag-Streit Diagnostics, Clement Clarke Ophthalmic, John Weiss, Optovue, Meridian, Haag-Streit Simulation, and Haag-Streit Surgical. It is also an Authorised UK Distributor for a number …

5 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology